Now showing items 1-1 of 1

  • The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas 

    Estupiñan, Oscar; Santos, Laura; Rodriguez, Aida; Fernandez-Nevado, Lucia; Costales, Paula; Perez‐Escuredo, Jhudit; Hermosilla, Maria Ana; Oro, Patricia; Rey, Veronica; Tornin Cavielles, Juan; Allonca, Eva; Fernandez Garcia, Maria Teresa; Alvarez Fernandez, Carlos; Braña, Alejandro; Astudillo, Aurora; T. Menendez, Sofia; Moris, Francisco; Rodriguez, Rene (Wiley (John Wiley & Sons), 2018-12-21)
    Article
    Restricted access - publisher's policy
    Cytotoxic drugs like doxorubicin remain as the most utilized agents in sarcoma treatment. However, advanced sarcomas are often resistant, thus stressing the need for new therapies aimed to overcome this resistance. Multikinase ...